1. Home
  2. DCTH vs CYH Comparison

DCTH vs CYH Comparison

Compare DCTH & CYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • CYH
  • Stock Information
  • Founded
  • DCTH 1988
  • CYH 1985
  • Country
  • DCTH United States
  • CYH United States
  • Employees
  • DCTH N/A
  • CYH N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • CYH Hospital/Nursing Management
  • Sector
  • DCTH Health Care
  • CYH Health Care
  • Exchange
  • DCTH Nasdaq
  • CYH Nasdaq
  • Market Cap
  • DCTH 388.3M
  • CYH 410.5M
  • IPO Year
  • DCTH N/A
  • CYH 1991
  • Fundamental
  • Price
  • DCTH $8.62
  • CYH $3.73
  • Analyst Decision
  • DCTH Strong Buy
  • CYH Hold
  • Analyst Count
  • DCTH 5
  • CYH 8
  • Target Price
  • DCTH $22.60
  • CYH $3.73
  • AVG Volume (30 Days)
  • DCTH 1.3M
  • CYH 2.8M
  • Earning Date
  • DCTH 11-04-2025
  • CYH 10-23-2025
  • Dividend Yield
  • DCTH N/A
  • CYH N/A
  • EPS Growth
  • DCTH N/A
  • CYH N/A
  • EPS
  • DCTH 0.03
  • CYH 2.47
  • Revenue
  • DCTH $79,603,000.00
  • CYH $12,644,000,000.00
  • Revenue This Year
  • DCTH $135.11
  • CYH N/A
  • Revenue Next Year
  • DCTH $36.30
  • CYH $2.46
  • P/E Ratio
  • DCTH $250.39
  • CYH $1.53
  • Revenue Growth
  • DCTH 251.54
  • CYH 0.74
  • 52 Week Low
  • DCTH $8.39
  • CYH $2.24
  • 52 Week High
  • DCTH $18.23
  • CYH $4.64
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 30.11
  • CYH 56.21
  • Support Level
  • DCTH $9.15
  • CYH $3.67
  • Resistance Level
  • DCTH $10.03
  • CYH $3.93
  • Average True Range (ATR)
  • DCTH 0.67
  • CYH 0.25
  • MACD
  • DCTH -0.21
  • CYH -0.00
  • Stochastic Oscillator
  • DCTH 5.71
  • CYH 49.25

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About CYH Community Health Systems Inc.

Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.

Share on Social Networks: